Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___	O
Chief	O
Complaint:	O
Chest	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
Coronary	O
artery	O
bypass	O
graft	O
x3,	O
left	O
internal	O
mammary	O
artery	O
to	O
left	O
anterior	O
descending,	O
reverse	O
saphenous	O
vein	O
graft	O
to	O
posterior	O
descending	O
artery,	O
and	O
reverse	O
saphenous	O
vein	O
graft	O
OM.	O
History	O
of	O
Present	O
Illness:	O
___	O
year	O
old	O
male	O
with	O
complaints	O
of	O
exertional	O
chest	O
pain	O
for	O
about	O
a	O
month	O
that	O
is	O
relieved	O
with	O
rest.	O
It	O
has	O
progressively	O
increased	O
over	O
time	O
until	O
now	O
when	O
the	O
pain	O
is	O
not	O
relieved	O
with	O
rest.	O
He	O
now	O
also	O
has	O
associated	O
dyspnea.	O
He	O
originally	O
presented	O
to	O
___	O
for	O
evaluation	O
and	O
was	O
found	O
to	O
have	O
ischemic	O
ECG	O
changes	O
and	O
an	O
abnormal	O
troponin.	O
Due	O
to	O
these	O
findings	O
he	O
was	O
transferred	O
to	O
___	O
for	O
cardiac	O
catheterization	O
and	O
was	O
found	O
to	O
have	O
left	O
main	O
disease.	O
Cardiac	O
surgery	O
consult	O
to	O
evaluate	O
for	O
urgent	O
CABG.	O
Past	O
Medical	O
History:	O
Coronary	O
Artery	O
Disease	O
s/p	O
MI	O
in	O
___	O
Hypertension	O
Hyperlipidemia	O
Oligodendroglioma:	O
Left	O
sided,	O
s/p	O
biopsy	O
and	O
XRT	O
in	O
___	O
with	O
no	O
recurrence	O
GERD	O
Prostate	O
Cancer	O
s/p	O
radiation	O
Skin	O
cancer	O
s/p	O
resection	O
and	O
MOHS	O
procedure	O
Past	O
Surgical	O
History:	O
Brain	O
biopsy	O
Appendectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
non-contributory	O
Physical	O
Exam:	O
Pulse:63	O
Resp:14	O
O2	O
sat:96/RA	O
B/P	O
Right:151/67	O
Left:140/76	O
Height:	O
5'5"	O
Weight:68	O
kg	O
General:	O
Skin:	O
Dry	O
[]	O
intact	O
[x]	O
HEENT:	O
PERRLA	O
[x]	O
EOMI	O
[x]	O
Neck:	O
Supple	O
[x]	O
Full	O
ROM	O
[x]	O
Chest:	O
Lungs	O
clear	O
bilaterally	O
[x]	O
Heart:	O
RRR	O
[x]	O
Irregular	O
[]	O
Murmur	O
[]	O
grade	O
______	O
Abdomen:	O
Soft	O
[x]	O
non-distended	O
[x]	O
non-tender	O
[x]	O
bowel	O
sounds	O
+	O
[]	O
Extremities:	O
Warm	O
[x],	O
well-perfused	O
[x]	O
Edema	O
trace[]	O
_____	O
Varicosities:	O
None	O
[x]	O
Neuro:	O
Grossly	O
intact	O
[x]	O
Pulses:	O
Femoral	O
Right:	O
+1	O
Left:+1	O
DP	O
Right:+1	O
Left:+1	O
___	O
Right:+1	O
Left:+1	O
Radial	O
Right:	O
cath	O
site	O
Left:+2	O
Carotid	O
Bruit	O
Right:none	O
Left:none	O
Pertinent	O
Results:	O
___	O
Final	O
Report	O
EXAMINATION:	O
CT	O
HEAD	O
W/O	O
CONTRAST	O
Q111	O
CT	O
HEAD	O
INDICATION:	O
___	O
man	O
fell	B-Falls
out	O
of	O
bed.	O
Evaluate	O
for	O
acute	O
intracranial	O
process.	O
TECHNIQUE:	O
Contiguous	O
axial	O
images	O
of	O
the	O
brain	O
were	O
obtained	O
without	O
contrast.	O
DOSE:	O
This	O
study	O
involved	O
3	O
CT	O
acquisition	O
phases	O
with	O
dose	O
indices	O
as	O
follows:	O
1)	O
CT	O
Localizer	O
Radiograph	O
2)	O
CT	O
Localizer	O
Radiograph	O
3)	O
Sequenced	O
Acquisition	O
16.0	O
s,	O
16.9	O
cm;	O
CTDIvol	O
=	O
47.4	O
mGy	O
(Head)	O
DLP	O
=	O
802.7	O
mGy-cm.	O
Total	O
DLP	O
(Head)	O
=	O
803	O
mGy-cm.	O
COMPARISON:	O
Noncontrast	O
CT	O
head	B-Intracranial_haemorrhage
___.	O
FINDINGS:	O
There	O
is	O
no	O
evidence	O
of	O
infarction,	O
hemorrhage,	B-Intracranial_haemorrhage
edema,	O
or	O
mass.	O
Hypodensity	O
within	O
the	O
left	O
frontal	O
lobe	O
is	O
related	O
to	O
prior	O
tumor	O
resection.	O
The	O
ventricles	O
and	O
sulci	O
are	O
prominent	O
consistent	O
with	O
age-related	O
atrophy.	O
Confluent	O
periventricular	O
and	O
subcortical	O
white	O
matter	O
hypodensities	O
likely	O
represent	O
the	O
sequela	O
of	O
chronic	O
small	O
vessel	O
ischemic	O
disease.	O
There	O
is	O
a	O
left	O
frontal	O
burr	O
hole.	O
The	O
visualized	O
portion	O
of	O
the	O
paranasal	O
sinuses	O
and	O
mastoid	O
air	O
cells	O
clear.	O
There	O
is	O
cerumen	O
in	O
the	O
right	O
external	O
auditory	O
canal.	O
The	O
left	O
external	O
auditory	O
canals	O
clear	O
The	O
visualized	O
portion	O
of	O
the	O
orbits	O
are	O
unremarkable.	O
Small	O
right	O
frontal	O
scalp	O
hematoma.	O
IMPRESSION:	O
1.	O
No	O
acute	O
intracranial	O
process.	O
2.	O
Small	O
right	O
frontal	O
scalp	O
hematoma.	O
.	O
___	O
04:44AM	O
BLOOD	O
WBC-12.5*	O
RBC-2.85*	O
Hgb-9.0*	O
Hct-26.7*	O
MCV-94	O
MCH-31.6	O
MCHC-33.7	O
RDW-13.8	O
RDWSD-46.7*	O
Plt	O
___	O
___	O
04:11AM	O
BLOOD	O
WBC-13.9*	O
RBC-2.31*	O
Hgb-7.2*	O
Hct-22.7*	O
MCV-98	O
MCH-31.2	O
MCHC-31.7*	O
RDW-12.9	O
RDWSD-45.8	O
Plt	O
___	O
___	O
07:40PM	O
BLOOD	O
WBC-18.2*#	O
RBC-2.89*#	O
Hgb-9.2*#	O
Hct-27.4*#	O
MCV-95	O
MCH-31.8	O
MCHC-33.6	O
RDW-12.8	O
RDWSD-44.4	O
Plt	O
___	O
___	O
02:43AM	O
BLOOD	O
___	O
PTT-28.1	O
___	O
___	O
06:00PM	O
BLOOD	O
___	O
PTT-26.5	O
___	O
___	O
04:44AM	O
BLOOD	O
Glucose-128*	O
UreaN-20	O
Creat-0.7	O
Na-134	O
K-4.6	O
Cl-100	O
HCO3-29	O
AnGap-10	O
___	O
01:19AM	O
BLOOD	O
Glucose-164*	O
UreaN-21*	O
Creat-1.0	O
Na-131*	O
K-4.1	O
Cl-100	O
HCO3-25	O
AnGap-10	O
___	O
12:40PM	O
BLOOD	O
ALT-26	O
AST-36	O
AlkPhos-20*	O
Amylase-89	O
TotBili-0.3	O
___	O
04:44AM	O
BLOOD	O
Mg-2.2	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
___	O
where	O
the	O
patient	O
underwent	O
CABG	O
x	O
3	O
with	O
Dr.	O
___.	O
Overall	O
the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
post-operatively	O
was	O
transferred	O
to	O
the	O
CVICU	O
in	O
stable	O
condition	O
for	O
recovery	O
and	O
invasive	O
monitoring.	O
POD	O
1	O
found	O
the	O
patient	O
extubated,	O
alert	O
and	O
oriented	B-Delirium
and	O
breathing	O
comfortably.	O
The	O
patient	O
was	O
neurologically	O
intact	O
and	O
hemodynamically	O
stable.	O
Beta	O
blocker	O
was	O
initiated	O
and	O
the	O
patient	O
was	O
gently	O
diuresed	O
toward	O
the	O
preoperative	O
weight.	O
Blood	O
was	O
given	O
for	O
post-op	O
blood	O
loss	O
anemia	O
with	O
good	O
effect.	O
The	O
patient	O
was	O
transferred	O
to	O
the	O
telemetry	O
floor	O
for	O
further	O
recovery.	O
He	O
did	O
sustain	O
an	O
unwitnessed	O
fall.	B-Falls
Head	O
CT	O
was	O
negative.	O
Chest	O
tubes	O
and	O
pacing	O
wires	O
were	O
discontinued	O
without	O
complication.	O
The	O
patient	O
was	O
evaluated	O
by	O
the	O
physical	O
therapy	O
service	O
for	O
assistance	O
with	O
strength	O
and	O
mobility.	O
By	O
the	O
time	O
of	O
discharge	O
on	O
POD	O
4	O
the	O
patient	O
was	O
ambulating	O
freely,	O
the	O
wound	O
was	O
healing	O
and	O
pain	O
was	O
controlled	O
with	O
oral	O
analgesics.	O
The	O
patient	O
was	O
discharged	O
to	O
___	O
in	O
___	O
in	O
good	O
condition	O
with	O
appropriate	O
follow	O
up	O
instructions.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Atenolol	O
50	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
3.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
4.	O
Cyanocobalamin	O
50	O
mcg	O
PO	O
DAILY	O
5.	O
Phenytoin	O
Sodium	O
Extended	O
100	O
mg	O
PO	O
BID	O
6.	O
Phenytoin	O
Sodium	O
Extended	O
100	O
mg	O
PO	O
4X/WEEK	O
(___)	O
Discharge	O
Medications:	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Atorvastatin	O
80	O
mg	O
PO	O
QPM	O
3.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
4.	O
Furosemide	O
40	O
mg	O
PO	O
DAILY	O
Duration:	O
10	O
Days	O
5.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
TID	O
6.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
8.	O
Potassium	O
Chloride	O
20	O
mEq	O
PO	O
BID	O
9.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q4H:PRN	O
pain,	O
___	O
10.	O
Cyanocobalamin	O
50	O
mcg	O
PO	O
DAILY	O
11.	O
Phenytoin	O
Sodium	O
Extended	O
100	O
mg	O
PO	O
TID	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Coronary	O
Artery	O
Disease	O
s/p	O
MI	O
in	O
___	O
Hypertension	O
Hyperlipidemia	O
Oligodendroglioma:	O
Left	O
sided,	O
s/p	O
biopsy	O
and	O
XRT	O
in	O
___	O
with	O
no	O
recurrence	O
GERD	O
Prostate	O
Cancer	O
s/p	O
radiation	O
Skin	O
cancer	O
s/p	O
resection	O
and	O
MOHS	O
procedure	O
Past	O
Surgical	O
History:	O
Brain	O
biopsy	O
Appendectomy	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	B-Delirium
x3	B-Delirium
nonfocal	O
Ambulating,	O
deconditioned	O
Sternal	O
pain	O
managed	O
with	O
oral	O
analgesics	O
Sternal	O
Incision	O
-	O
healing	O
well,	O
no	O
erythema	O
or	O
drainage	O
Staples	O
in	O
LLE	O
to	O
be	O
discontinued	O
___	O
Edema-	O
trace	O
Discharge	O
Instructions:	O
Please	O
shower	O
daily	O
including	O
washing	O
incisions	O
gently	O
with	O
mild	O
soap,	O
no	O
baths	O
or	O
swimming,	O
and	O
look	O
at	O
your	O
incisions	O
Please	O
NO	O
lotions,	O
cream,	O
powder,	O
or	O
ointments	O
to	O
incisions	O
Each	O
morning	O
you	O
should	O
weigh	O
yourself	O
and	O
then	O
in	O
the	O
evening	O
take	O
your	O
temperature,	O
these	O
should	O
be	O
written	O
down	O
on	O
the	O
chart	O
No	O
driving	O
for	O
approximately	O
one	O
month	O
and	O
while	O
taking	O
narcotics,	O
will	O
be	O
discussed	O
at	O
follow	O
up	O
appointment	O
with	O
surgeon	O
when	O
you	O
will	O
be	O
able	O
to	O
drive	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O
___	O
**Please	O
call	O
cardiac	O
surgery	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
___.	O
Answering	O
service	O
will	O
contact	O
on	O
call	O
person	O
during	O
off	O
hours**	O
Followup	O
Instructions:	O
___	O

